Market Tracker

04/17 6:02pm ET

Paratek Pharmaceuticals Inc (NASDAQ:PRTK)

28.38
Delayed Data
As of Apr 17
 -1.18 / -3.99%
Today’s Change
11.34
Today|||52-Week Range
39.80
-26.38%
Year-to-Date
No recent news for Paratek Pharmaceuticals Inc.

Today’s Trading

Previous close29.56
Today’s open29.14
Day’s range27.23 - 29.46
Volume33,638
Average volume (3 months)35,470
Market cap$409.2M
Dividend yield2.36%
Data as of 3:59pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+55.37%
Earnings growth (this year)+68.67%
Earnings growth (next 5 years)--
Revenue growth (last year)+148.54%
P/E ratioNM
Price/Sales22.45
Price/Book--

Competitors

 Today’s
change
Today’s
% change
SRNESorrento Therapeutic...+0.16+1.43%
AMPEAmpio Pharmaceutical...-0.10-1.25%
IDRAIdera Pharmaceutical...-0.14-3.90%
VNDAVanda Pharmaceutical...-0.19-1.88%
Data as of 4:03pm ET, 04/17/2015

Financials

Last reporting dateNovember 13, 2014
EPS forecast (this quarter)-$10.38
Annual revenue (last year)$4.3M
Annual profit (last year)-$17.8M
Net profit margin-410.76%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Michael F. Bigham
President, Director &
Chief Medical Officer
Evan Loh
Corporate headquarters
Boston, Massachusetts

Forecasts